Total estimated DM population size through 2030 in base-, worst- and best-case scenario.

<p>Total estimated DM population size through 2030 in base-, worst- and best-case scenario.</p

Summary of the literature review for cost of DM (all costs are in 2009 US$).

<p>† Cost were adjusted based on the market exchange rate where official exchange rate were used</p><p>†† Total estimated cost for all diabetic patients (2,948,637) was 2661.9 million, yielding a mean annual cost of 902.75 US$</p><p>*Adjusted average cost for type 1 and Type 2 DM patient</p><p>** Only includes lost work days</p><p>Summary of the literature review for cost of DM (all costs are in 2009 US$).</p

Total estimated diagnosed and undiagnosed DM population size through 2030.

<p>Total estimated diagnosed and undiagnosed DM population size through 2030.</p

Total estimated direct cost of DM through 2030 in base-, worst- and best-case scenario.

<p>Total estimated direct cost of DM through 2030 in base-, worst- and best-case scenario.</p

Total estimated indirect cost of DM through 2030 in base-, worst- and best-case scenario.

<p>Total estimated indirect cost of DM through 2030 in base-, worst- and best-case scenario.</p

Markov model structure.

<p>Markov model structure.</p

Characteristics of the patients.

<p>Characteristics of the patients.</p

Total estimated direct and indirect cost of DM through 2030.

<p>Total estimated direct and indirect cost of DM through 2030.</p

EQ-5D and Visual Analog Scale (VAS) scores.

<p>Notes: EQ-5D and VAS scores: mean values adjusted by sex, age, education, marriage and employment status, diabetes duration and comorbidities; <i>P</i>-value: ANCOVA. No marks: not significant. VAS: visual analog scale.</p

Results of multivariate logistic regression models.

<p>Notes: OR: Odds Ratio; Ref: reference group, No marks: not significant.</p